pentetic acid has been researched along with methylprednisolone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (92.31) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barkhof, F; Frequin, ST; Hommes, OR; Lamers, K; Scheltens, P; Valk, J; van Geel, WJ | 1 |
| Barkhof, F; Hommes, OR; Scheltens, P; Valk, J | 1 |
| Burnham, JA; Dreisbach, J; Murray, RS; Wright, RR | 1 |
| Anno, H; Koga, S; Miyata, E; Nomura, M; Suzumura, A; Yamamoto, H | 1 |
| Barkhof, F; Frequin, ST; Hommes, OR; Nauta, JJ; Scheltens, P; Tas, MW; Valk, J | 1 |
| Goodkin, DE; Ross, JS; Rudick, RA | 1 |
| Kuroki, M; Okano, R; Otsuka, M; Ueki, A; Yamada, A | 1 |
| Albert, PS; Armstrong, M; Frank, JA; Maloni, H; Martin, R; McFarland, HF; McFarlin, DE; Smith, ME; Stone, LA | 1 |
| Henriksen, O; Lorenzen, I; Ostergaard, M; Stoltenberg, M | 1 |
| Christiansen, P; Jensen, CV; Nordenbo, A; Ravnborg, M; Schreiber, K; Szpirt, W; Sørensen, PS; Wanscher, B | 1 |
| Hartmann, M; Hohlfeld, R; Holler, E; Scheller, A; Spuler, S; Voltz, R; Wick, M; Yousry, T | 1 |
| Bonavolonta, G; Colao, A; Fenzi, G; Ferone, D; Lastoria, S; Lombardi, G; Macchia, PE; Muto, P; Pivonello, R; Vassallo, P | 1 |
2 review(s) available for pentetic acid and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The use of brain magnetic resonance imaging in multiple sclerosis.
Topics: Brain; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Nervous System Diseases; Neuropsychological Tests; Organometallic Compounds; Pentetic Acid | 1994 |
3 trial(s) available for pentetic acid and methylprednisolone
| Article | Year |
|---|---|
[Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
Topics: Acute Disease; Adolescent; Adult; Aged; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases | 1995 |
Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study.
Topics: Adult; Autoimmune Diseases; Azathioprine; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pilot Projects; Plasma Exchange; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 1996 |
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Topics: Adult; Female; Glucocorticoids; Graves Disease; Humans; Indium Radioisotopes; Male; Methylprednisolone; Middle Aged; Octreotide; Orbit; Pentetic Acid; Prognosis; Radionuclide Imaging; Treatment Outcome | 1998 |
8 other study(ies) available for pentetic acid and methylprednisolone
| Article | Year |
|---|---|
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Topics: Adult; Contrast Media; Disability Evaluation; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Organometallic Compounds; Pentetic Acid | 1992 |
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions.
Topics: Adult; Blood-Brain Barrier; Brain; Encephalomyelitis; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Time Factors | 1994 |
[Leptomeningeal abnormality on Gd-DTPA enhanced MRI in a case of SLE presenting diffuse organic brain syndrome].
Topics: Adult; Arachnoid; Female; Gadolinium DTPA; Humans; Image Enhancement; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Neurocognitive Disorders; Organometallic Compounds; Pentetic Acid; Pia Mater | 1993 |
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
Topics: Adult; Brain; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prednisone; Recurrence; Remission, Spontaneous; Spine; Time Factors; Visual Acuity | 1993 |
Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced magnetic resonance imaging. A study of the effect of intra-articular methylprednisolone on the rate of early synovial enhancement.
Topics: Anti-Inflammatory Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Follow-Up Studies; Gadolinium DTPA; Humans; Injections, Intra-Articular; Knee Joint; Longitudinal Studies; Magnetic Resonance Imaging; Methylprednisolone; Observer Variation; Organometallic Compounds; Pentetic Acid; Remission Induction; Synovitis; Time Factors | 1996 |
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity.
Topics: Adult; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Receptors, Tumor Necrosis Factor; Recurrence; Tumor Necrosis Factor-alpha | 1996 |